Clinical Laserthermia Systems AB (publ) (CLS-B) — Financial Flexibility Index
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Financial Flexibility Index of -0.01x as of June 2026. Free cash flow of Skr-297.00K (operating CF Skr-4.73 Million minus capex Skr4.43 Million) represents 0% of total liabilities (Skr22.07 Million). Check Clinical Laserthermia Systems AB (publ) (CLS-B) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Clinical Laserthermia Systems AB (publ) Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Clinical Laserthermia Systems AB (publ) across 18 annual periods. For the full cash flow conversion analysis, see CLS-B cash generation efficiency.
Annual Financial Flexibility Index for Clinical Laserthermia Systems AB (publ) (2008–2025)
Year-by-year free cash flow to debt coverage for Clinical Laserthermia Systems AB (publ). Explore Clinical Laserthermia Systems AB (publ) debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.04x | Skr-30.41 Million | Skr-33.20 Million | Skr10.00 Million | ▲ +27.5% |
| 2024 | -4.19x | Skr-53.99 Million | Skr-56.45 Million | Skr12.88 Million | ▲ +2.3% |
| 2023 | -4.29x | Skr-60.96 Million | Skr-66.45 Million | Skr14.20 Million | ▼ -155.0% |
| 2022 | -1.68x | Skr-70.13 Million | Skr-70.69 Million | Skr41.64 Million | ▼ -16.9% |
| 2021 | -1.44x | Skr-65.62 Million | Skr-66.17 Million | Skr45.55 Million | ▲ +20.3% |
| 2020 | -1.81x | Skr-55.06 Million | Skr-55.41 Million | Skr30.47 Million | ▼ -47.6% |
| 2019 | -1.22x | Skr-38.77 Million | Skr-39.12 Million | Skr31.67 Million | ▲ +72.3% |
| 2018 | -4.43x | Skr-36.35 Million | Skr-38.72 Million | Skr8.21 Million | ▼ -168.1% |
| 2017 | -1.65x | Skr-19.71 Million | Skr-24.39 Million | Skr11.94 Million | ▲ +6.5% |
| 2016 | -1.77x | Skr-18.09 Million | Skr-19.63 Million | Skr10.24 Million | ▲ +70.5% |
| 2015 | -5.98x | Skr-16.78 Million | Skr-18.68 Million | Skr2.81 Million | ▼ -141.3% |
| 2014 | -2.48x | Skr-13.33 Million | Skr-15.74 Million | Skr5.38 Million | ▲ +51.4% |
| 2013 | -5.10x | Skr-15.86 Million | Skr-18.30 Million | Skr3.11 Million | ▼ -51.6% |
| 2012 | -3.36x | Skr-9.99 Million | Skr-12.05 Million | Skr2.97 Million | ▼ -75.5% |
| 2011 | -1.92x | Skr-4.17 Million | Skr-5.96 Million | Skr2.17 Million | ▲ +10.6% |
| 2010 | -2.14x | Skr-3.01 Million | Skr-4.92 Million | Skr1.41 Million | ▼ -424.7% |
| 2009 | 0.66x | Skr1.04 Million | Skr-2.28 Million | Skr1.57 Million | ▼ -37.2% |
| 2008 | 1.05x | Skr1.94 Million | Skr-69.30K | Skr1.85 Million | — |